This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Duke University. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Allan H Friedman: Innovator in Cancer Treatment
Introduction
Allan H Friedman is a prominent inventor in the field of cancer treatment. He has made significant contributions to the development of innovative therapies aimed at combating various types of tumors. His work focuses on utilizing a chimeric poliovirus construct to enhance anti-tumor effects in patients.
Latest Patents
Allan H Friedman currently holds 1 patents. However, his research on Sequential Anti-Cancer Treatment has shown promising results in human clinical use. The combination of the poliovirus construct followed by chemotherapy drugs has demonstrated an excellent anti-tumor effect.
Career Highlights
Friedman's career is marked by his dedication to advancing cancer treatment methodologies. His innovative approach has opened new avenues for treating tumors that are typically resistant to conventional therapies. The Sequential Anti-Cancer Treatment has shown effectiveness against various cancers, including melanoma, glioblastoma, renal cell carcinoma, prostate cancer, breast cancer, lung cancer, medulloblastoma, and colorectal cancer.
Collaborations
Throughout his career, Allan H Friedman has collaborated with notable researchers, including Darell D Bigner and Matthias Gromeier. These partnerships have been instrumental in furthering the research and application of his innovative treatment strategies.
Conclusion
Allan H Friedman is a key figure in the fight against cancer, with his research paving the way for new treatment options. His work exemplifies the potential of innovative therapies in improving patient outcomes.